参考文献
[1]Tian DC，Zhang C，Yuan M，et al.Incidence of multiple sclerosis in China:A nationwide hospital-based study[J].The Lancet Regional Health，Western Pacific，2020，1:100010.
[2]Thompson BS.Multiple regression of cost data:use of generalised linear models[J].J Health Serv Res Policy，2004，9（4）:197-204.
[3]World Health Organization.Distribution of health payments and catastrophic expenditures Methodology[M].Geneva:World Health Organization，2005.
[4]Ta Y，Zhu Y，Fu H.Trends in access to health services，financial protection and satisfaction between 2010 and 2016:Has China achieved the goals of its health system reform？[J].Social Science&Medicine，2019，245:112715.
[5]Fu XZ.The comparison of catastrophic health expenditure and its inequality between urban and rural households in China[J].Health Economics Review，2022，12（1）:1-17.
[6]García-Domínguez JM，Maurino J，Martínez-Ginés ML，et al.Economic burden of multiple sclerosis in a population with low physical disability[J].BMC Public Health，2019，19（1）:609.
[7]Ness NH，Schriefer D，Haase R，et al.Differentiating societal costs of disability worsening in multiple sclerosis[J].Journal of Neurology，2020，267（4）:1035-1042.
[8]Schriefer D，Ness NH，Haase R，et al.Gender disparities in health resource utilization in patients with relapsing-remitting multiple sclerosis:a prospective longitudinal real-world study with more than 2000 patients:[J].Therapeutic Advances in Neurological Disorders，2020，13:1502-1517.(https://www.daowen.com)
[9]Brown LJ，Li J，Brunner M，et al.Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression[J].Journal of Medical Economics，2021，24（1）:140-149.
[10]Carney P，O'Boyle D，Larkin A，et al.Societal costs of multiple sclerosis in Ireland[J/OL].Journal of Medical Economics，2018，21（5）:425-437.
[11]人民网.我国首部《多发性硬化患者生存报告（2018）》发布[EB/OL].（2019-02-25）[2022-05-26].http：//health.people.com.cn/n1/2019/0225/c14739-30901332.html.
[12]Guojun T，Yan X，Weizhi W，et al.A multicenter study to evaluate the disease burden and health economics of inpatients with multiple sclerosis in China[J].Multiple Sclerosis and Related Disorders，2022，60:103732.
[13]Du Y，Min R，Zhang X，et al.Factors associated with the healthcare expenditures of patients with multiple sclerosis in urban areas of China estimated by a generalized estimating equation[J].Expert Review of Pharmacoeconomics&Outcomes Research，2021，21（1）:137-144.
[14]Jones E，Pike J，Marshall T，et al.Quantifying the relationship between increased disability and health care resource utilization，quality of life，work productivity，health care costs in patients with multiple sclerosis in the US[J].Bmc Health Services Research，2016，16（1）:294.
[15]Bruno D，Marc D，Ouarda P，et al.Economic burden of multiple sclerosis in France estimated from a regional medical registry and national sick fund claims[J].Multiple Sclerosis and Related Disorders，2019，36:101396.
[16]Sicras-Mainar A，Ruíz-Beato E，Navarro-Artieda R，et al.Impact on healthcare resource utilization of multiple sclerosis in Spain[J].BMC Health Services Research，2017，17（1）:854.